BioCryst Appoints Anthony Doyle Chief Financial Officer

Go back to BioCryst Appoints Anthony Doyle Chief Financial Officer
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.65 +0.34 (3.65%)
Previous Close $9.31    52 Week High $10.98 
Open $9.42    52 Week Low $1.63 
Day High $9.74    P/E N/A 
Day Low $9.39    EPS $-0.68 
Volume 3,555,400